Martin J Connor

Specialty Registrar & Senior Clinical Research Fellow in Urology

Imperial Prostate, Division of Surgery, Department of Surgery and Cancer; and Department of Urology; Imperial College London, Charing Cross Hospital, London.

Latest Contribution

Map showing global portfolio of randomised trials offering cytoreductive surgery in de novo synchronous metastatic prostate cancer.

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | Basic Science Research, Urologic Oncology

Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

Photo showing image-fusion targeted transperineal prostate biopsy.

Visual-estimation (cognitive), image-fusion (software) and in-bore targeted prostate biopsy: is there an optimal approach?

3 March 2021 | | Urologic Oncology, Technological Developments

The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...